Researchers identify a new cell mechanism that connects Alzheimer's disease and cancers.
Researchers implicate presenilin and GSK-3b in the development of Alzheimer's disease.
Incorrect levels of GSK-3ß, a protein linked to Alzheimer's disease, can lead to neural blockages.
Researchers discover presenilin, a protein associated with Alzheimer's disease, controls the speed at which materials move through brain cells. Defects in presenilin could lead to neuronal blockages with amyloid plaques, commonly associated with this neurodegenerative disorder.
